The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions For Improving Cell Viability And Methods Of Use Thereof - EP2978419

The patent EP2978419 was granted to Amylyx Pharmaceuticals on Apr 15, 2020. The application was filed on Feb 24, 2014 under application number EP14775675A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2978419

AMYLYX PHARMACEUTICALS
Application Number
EP14775675A
Filing Date
Feb 24, 2014
Status
Opposition Rejected
Oct 21, 2022
Publication Date
Apr 15, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBJan 12, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB -
BRUSCHETTINIJan 11, 2021PISTOLESI -

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2006050165
INTERNATIONAL-SEARCH-REPORTUS2009312297
INTERNATIONAL-SEARCH-REPORTUS2011142799
INTERNATIONAL-SEARCH-REPORTUS2012157419
OPPOSITIONEP2599477
OPPOSITIONWO2006050165
OPPOSITIONWO2009140265
OPPOSITIONWO2013142490
OPPOSITIONWO2014158547
SEARCHEP2599477
SEARCHWO2006050165
SEARCHWO2009140265

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents